Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Serum neurofilament light chain in progressive supranuclear palsy.

Donker Kaat L, Meeter LH, Chiu WZ, Melhem S, Boon AJW, Blennow K, Zetterberg H, van Swieten JC.

Parkinsonism Relat Disord. 2018 Jun 12. pii: S1353-8020(18)30277-3. doi: 10.1016/j.parkreldis.2018.06.018. [Epub ahead of print]

PMID:
29937097
2.

Poly(GP), neurofilament and grey matter deficits in C9orf72 expansion carriers.

Meeter LHH, Gendron TF, Sias AC, Jiskoot LC, Russo SP, Donker Kaat L, Papma JM, Panman JL, van der Ende EL, Dopper EG, Franzen S, Graff C, Boxer AL, Rosen HJ, Sanchez-Valle R, Galimberti D, Pijnenburg YAL, Benussi L, Ghidoni R, Borroni B, Laforce R Jr, Del Campo M, Teunissen CE, van Minkelen R, Rojas JC, Coppola G, Geschwind DH, Rademakers R, Karydas AM, Öijerstedt L, Scarpini E, Binetti G, Padovani A, Cash DM, Dick KM, Bocchetta M, Miller BL, Rohrer JD, Petrucelli L, van Swieten JC, Lee SE.

Ann Clin Transl Neurol. 2018 Apr 6;5(5):583-597. doi: 10.1002/acn3.559. eCollection 2018 May.

3.

Longitudinal cognitive biomarkers predicting symptom onset in presymptomatic frontotemporal dementia.

Jiskoot LC, Panman JL, van Asseldonk L, Franzen S, Meeter LHH, Donker Kaat L, van der Ende EL, Dopper EGP, Timman R, van Minkelen R, van Swieten JC, van den Berg E, Papma JM.

J Neurol. 2018 Jun;265(6):1381-1392. doi: 10.1007/s00415-018-8850-7. Epub 2018 Apr 7.

4.

Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum.

Meeter LHH, Vijverberg EG, Del Campo M, Rozemuller AJM, Donker Kaat L, de Jong FJ, van der Flier WM, Teunissen CE, van Swieten JC, Pijnenburg YAL.

Neurology. 2018 Apr 3;90(14):e1231-e1239. doi: 10.1212/WNL.0000000000005261. Epub 2018 Mar 7.

5.

Cognition and gray and white matter characteristics of presymptomatic C9orf72 repeat expansion.

Papma JM, Jiskoot LC, Panman JL, Dopper EG, den Heijer T, Donker Kaat L, Pijnenburg YAL, Meeter LH, van Minkelen R, Rombouts SARB, van Swieten JC.

Neurology. 2017 Sep 19;89(12):1256-1264. doi: 10.1212/WNL.0000000000004393. Epub 2017 Aug 30.

PMID:
28855404
6.

Imaging and fluid biomarkers in frontotemporal dementia.

Meeter LH, Kaat LD, Rohrer JD, van Swieten JC.

Nat Rev Neurol. 2017 Jul;13(7):406-419. doi: 10.1038/nrneurol.2017.75. Epub 2017 Jun 16. Review.

PMID:
28621768
7.

Progranulin Levels in Plasma and Cerebrospinal Fluid in Granulin Mutation Carriers.

Meeter LH, Patzke H, Loewen G, Dopper EG, Pijnenburg YA, van Minkelen R, van Swieten JC.

Dement Geriatr Cogn Dis Extra. 2016 Jul 22;6(2):330-340. eCollection 2016 May-Aug.

8.

Neurofilament light chain: a biomarker for genetic frontotemporal dementia.

Meeter LH, Dopper EG, Jiskoot LC, Sanchez-Valle R, Graff C, Benussi L, Ghidoni R, Pijnenburg YA, Borroni B, Galimberti D, Laforce RJ, Masellis M, Vandenberghe R, Ber IL, Otto M, van Minkelen R, Papma JM, Rombouts SA, Balasa M, Öijerstedt L, Jelic V, Dick KM, Cash DM, Harding SR, Jorge Cardoso M, Ourselin S, Rossor MN, Padovani A, Scarpini E, Fenoglio C, Tartaglia MC, Lamari F, Barro C, Kuhle J, Rohrer JD, Teunissen CE, van Swieten JC.

Ann Clin Transl Neurol. 2016 Jul 1;3(8):623-36. doi: 10.1002/acn3.325. eCollection 2016 Aug.

9.

Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics.

Teunissen CE, Elias N, Koel-Simmelink MJ, Durieux-Lu S, Malekzadeh A, Pham TV, Piersma SR, Beccari T, Meeter LH, Dopper EG, van Swieten JC, Jimenez CR, Pijnenburg YA.

Alzheimers Dement (Amst). 2016 Jan 19;2:86-94. doi: 10.1016/j.dadm.2015.12.004. eCollection 2016.

Supplemental Content

Loading ...
Support Center